Search

Amber D. Steele

Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )

Most Active Art Unit
1658
Art Unit(s)
1654, 1639, 1658, 1676
Total Applications
1302
Issued Applications
628
Pending Applications
166
Abandoned Applications
538

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6254802 [patent_doc_number] => 20100028960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'Preparation of Precisely Controlled Thin Film Nanocomposite of Carbon Nanotubes and Biomaterials' [patent_app_type] => utility [patent_app_number] => 12/261892 [patent_app_country] => US [patent_app_date] => 2008-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 8844 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028960.pdf [firstpage_image] =>[orig_patent_app_number] => 12261892 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/261892
Preparation of Precisely Controlled Thin Film Nanocomposite of Carbon Nanotubes and Biomaterials Oct 29, 2008 Abandoned
Array ( [id] => 9153799 [patent_doc_number] => 08586706 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-19 [patent_title] => 'Peptide vaccine using mimic molecules of amyloid β peptide' [patent_app_type] => utility [patent_app_number] => 12/739651 [patent_app_country] => US [patent_app_date] => 2008-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6664 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12739651 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/739651
Peptide vaccine using mimic molecules of amyloid β peptide Oct 21, 2008 Issued
Array ( [id] => 9166874 [patent_doc_number] => 08592552 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-26 [patent_title] => 'Antiviral peptides from african swine fever virus which prevent the binding of the virus to DLC8' [patent_app_type] => utility [patent_app_number] => 12/739415 [patent_app_country] => US [patent_app_date] => 2008-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10432 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12739415 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/739415
Antiviral peptides from african swine fever virus which prevent the binding of the virus to DLC8 Oct 19, 2008 Issued
Array ( [id] => 7756720 [patent_doc_number] => 20120028910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'STORAGE-STABLE AQUEOUS OPHTHALMIC FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/681982 [patent_app_country] => US [patent_app_date] => 2008-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9361 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20120028910.pdf [firstpage_image] =>[orig_patent_app_number] => 12681982 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/681982
STORAGE-STABLE AQUEOUS OPHTHALMIC FORMULATIONS Oct 7, 2008 Abandoned
Array ( [id] => 5270896 [patent_doc_number] => 20090074672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Tumor Boundary Imaging' [patent_app_type] => utility [patent_app_number] => 12/212646 [patent_app_country] => US [patent_app_date] => 2008-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1583 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074672.pdf [firstpage_image] =>[orig_patent_app_number] => 12212646 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/212646
Tumor Boundary Imaging Sep 16, 2008 Abandoned
Array ( [id] => 6495527 [patent_doc_number] => 20100286070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'AFFINITY TAG' [patent_app_type] => utility [patent_app_number] => 12/733591 [patent_app_country] => US [patent_app_date] => 2008-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 14311 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286070.pdf [firstpage_image] =>[orig_patent_app_number] => 12733591 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/733591
AFFINITY TAG Sep 14, 2008 Abandoned
Array ( [id] => 6514344 [patent_doc_number] => 20100216724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'USE OF FIBRONECTIN FRAGMENT (196-203 ) AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677553 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34235 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216724.pdf [firstpage_image] =>[orig_patent_app_number] => 12677553 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/677553
USE OF FIBRONECTIN FRAGMENT (196-203 ) AS A THERAPEUTIC AGENT Sep 8, 2008 Abandoned
Array ( [id] => 6535663 [patent_doc_number] => 20100204157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'USE OF A PEPTIDE AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677566 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34082 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204157.pdf [firstpage_image] =>[orig_patent_app_number] => 12677566 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/677566
USE OF A PEPTIDE AS A THERAPEUTIC AGENT Sep 8, 2008 Abandoned
Array ( [id] => 6535327 [patent_doc_number] => 20100204140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'USE OF A PEPTIDE AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677302 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33614 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204140.pdf [firstpage_image] =>[orig_patent_app_number] => 12677302 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/677302
USE OF A PEPTIDE AS A THERAPEUTIC AGENT Sep 8, 2008 Abandoned
Array ( [id] => 6534401 [patent_doc_number] => 20100204090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'USE OF A PEPTIDE AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677547 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33819 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204090.pdf [firstpage_image] =>[orig_patent_app_number] => 12677547 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/677547
USE OF A PEPTIDE AS A THERAPEUTIC AGENT Sep 8, 2008 Abandoned
Array ( [id] => 6535651 [patent_doc_number] => 20100204156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'USE OF THYMOPENTIN AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677514 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34099 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204156.pdf [firstpage_image] =>[orig_patent_app_number] => 12677514 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/677514
USE OF THYMOPENTIN AS A THERAPEUTIC AGENT Sep 8, 2008 Abandoned
Array ( [id] => 6535353 [patent_doc_number] => 20100204142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'USE OF THE PEPTIDE PHPFHLFVY (RENIN INHIBITOR) AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677356 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34144 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204142.pdf [firstpage_image] =>[orig_patent_app_number] => 12677356 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/677356
USE OF THE PEPTIDE PHPFHLFVY (RENIN INHIBITOR) AS A THERAPEUTIC AGENT Sep 8, 2008 Abandoned
Array ( [id] => 6506919 [patent_doc_number] => 20100210559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'TRAP-14 AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677749 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33993 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210559.pdf [firstpage_image] =>[orig_patent_app_number] => 12677749 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/677749
TRAP-14 AS A THERAPEUTIC AGENT Sep 8, 2008 Abandoned
Array ( [id] => 6535338 [patent_doc_number] => 20100204141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'USE OF BPP-B AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677317 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33918 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204141.pdf [firstpage_image] =>[orig_patent_app_number] => 12677317 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/677317
USE OF BPP-B AS A THERAPEUTIC AGENT Sep 8, 2008 Abandoned
Array ( [id] => 5285367 [patent_doc_number] => 20090099042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'Reverse Two-Hybrid System for Identification of Interaction Domains' [patent_app_type] => utility [patent_app_number] => 12/206562 [patent_app_country] => US [patent_app_date] => 2008-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 28066 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099042.pdf [firstpage_image] =>[orig_patent_app_number] => 12206562 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/206562
Reverse Two-Hybrid System for Identification of Interaction Domains Sep 7, 2008 Abandoned
Array ( [id] => 11191562 [patent_doc_number] => 09422363 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-23 [patent_title] => 'Synthetic apolipoprotein E mimicking polypeptides and methods of use' [patent_app_type] => utility [patent_app_number] => 12/675089 [patent_app_country] => US [patent_app_date] => 2008-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 22552 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12675089 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/675089
Synthetic apolipoprotein E mimicking polypeptides and methods of use Aug 26, 2008 Issued
Array ( [id] => 10186826 [patent_doc_number] => 09216235 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-22 [patent_title] => 'Photoactivated crosslinking of a protein or peptide' [patent_app_type] => utility [patent_app_number] => 12/673400 [patent_app_country] => US [patent_app_date] => 2008-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 16965 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12673400 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/673400
Photoactivated crosslinking of a protein or peptide Aug 13, 2008 Issued
Array ( [id] => 6102580 [patent_doc_number] => 20110166073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'ANTI-HYPERTENSIVE AGENT' [patent_app_type] => utility [patent_app_number] => 12/671953 [patent_app_country] => US [patent_app_date] => 2008-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7047 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166073.pdf [firstpage_image] =>[orig_patent_app_number] => 12671953 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/671953
Anti-hypertensive agent Aug 6, 2008 Issued
Array ( [id] => 5962329 [patent_doc_number] => 20110147218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'SOLUBLE CADHERIN 17 FOR THE DIAGNOSIS AND RISK STRATIFICATION OF CANCER AND TUMOR OF THE GASTROINTESTINAL TRACT' [patent_app_type] => utility [patent_app_number] => 12/670533 [patent_app_country] => US [patent_app_date] => 2008-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3602 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20110147218.pdf [firstpage_image] =>[orig_patent_app_number] => 12670533 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/670533
SOLUBLE CADHERIN 17 FOR THE DIAGNOSIS AND RISK STRATIFICATION OF CANCER AND TUMOR OF THE GASTROINTESTINAL TRACT Jul 27, 2008 Abandoned
Array ( [id] => 5324152 [patent_doc_number] => 20090062142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Methods for enhancing bacterial cell display of proteins and peptides' [patent_app_type] => utility [patent_app_number] => 12/220448 [patent_app_country] => US [patent_app_date] => 2008-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19928 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062142.pdf [firstpage_image] =>[orig_patent_app_number] => 12220448 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/220448
Methods for enhancing bacterial cell display of proteins and peptides Jul 23, 2008 Issued
Menu